EA200800065A1 - Аминокислые соли росиглитазона - Google Patents

Аминокислые соли росиглитазона

Info

Publication number
EA200800065A1
EA200800065A1 EA200800065A EA200800065A EA200800065A1 EA 200800065 A1 EA200800065 A1 EA 200800065A1 EA 200800065 A EA200800065 A EA 200800065A EA 200800065 A EA200800065 A EA 200800065A EA 200800065 A1 EA200800065 A1 EA 200800065A1
Authority
EA
Eurasian Patent Office
Prior art keywords
rosiglitazone
amino acid
acid salts
salts
enantiomeric
Prior art date
Application number
EA200800065A
Other languages
English (en)
Other versions
EA012594B1 (ru
Inventor
Удо Верц
Герхард Мас
Генрих Шталь
Original Assignee
Рациофарм Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рациофарм Гмбх filed Critical Рациофарм Гмбх
Publication of EA200800065A1 publication Critical patent/EA200800065A1/ru
Publication of EA012594B1 publication Critical patent/EA012594B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

В заявке описаны новые аминокислые соли рацемической или энантиомерной либо таутомерной формы росиглитазона (химическое название: 5-(4-[2-(N-метил-N-(2-пиридил)амино)этокси]бензил)-2,4-тиазолидиндион), а также сольваты этих солей.
EA200800065A 2005-07-22 2006-07-20 Аминокислые соли росиглитазона EA012594B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005034406A DE102005034406A1 (de) 2005-07-22 2005-07-22 Neue Salze von Rosiglitazon
PCT/EP2006/007171 WO2007009799A1 (de) 2005-07-22 2006-07-20 Aminosäuresalze von rosiglitazon

Publications (2)

Publication Number Publication Date
EA200800065A1 true EA200800065A1 (ru) 2008-08-29
EA012594B1 EA012594B1 (ru) 2009-10-30

Family

ID=36870547

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200800065A EA012594B1 (ru) 2005-07-22 2006-07-20 Аминокислые соли росиглитазона

Country Status (18)

Country Link
US (1) US20080207700A1 (ru)
EP (1) EP1907386B1 (ru)
JP (1) JP2009502760A (ru)
KR (1) KR20080032108A (ru)
CN (1) CN101228157A (ru)
AT (1) ATE469896T1 (ru)
AU (1) AU2006271863A1 (ru)
BR (1) BRPI0613686A2 (ru)
CA (1) CA2616031A1 (ru)
DE (2) DE102005034406A1 (ru)
EA (1) EA012594B1 (ru)
ES (1) ES2344662T3 (ru)
IL (1) IL188661A0 (ru)
NO (1) NO20080704L (ru)
NZ (1) NZ565159A (ru)
UA (1) UA92354C2 (ru)
WO (1) WO2007009799A1 (ru)
ZA (1) ZA200800184B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
MX349923B (es) 2009-04-03 2017-08-21 Hoffmann La Roche Composiciones del ácido propano-1-sulfónico {3-[5-(4-cloro-fenil)- 1h-pirrolo [2,3-b]-piridina-3-carbonil]-2,4-difluoro-fenil]-amida y el uso de las mismas.
TW201041888A (en) 2009-05-06 2010-12-01 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
ES2633317T3 (es) 2009-11-06 2017-09-20 Plexxikon, Inc. Compuestos y métodos para la modulación de quinasas, e indicaciones para ello
MY162950A (en) 2011-02-07 2017-07-31 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
US9030870B2 (en) * 2011-08-26 2015-05-12 Micron Technology, Inc. Threshold voltage compensation in a multilevel memory
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
US9815777B2 (en) * 2013-09-22 2017-11-14 Jiva Pharma, Inc. Metformin salts to treat Type2 diabetes
CN107789352A (zh) * 2017-10-25 2018-03-13 桂林浩新科技服务有限公司 一种复方药物制剂及在制备治疗高血糖、高血脂的药物中的应用
CN109053718B (zh) * 2018-08-09 2022-06-03 天津理工大学 一种罗格列酮糖精盐及其制备方法
CN109053717B (zh) * 2018-08-09 2022-05-31 天津理工大学 一种罗格列酮龙胆酸盐及其制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB0014006D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0019224D0 (en) * 2000-08-04 2000-09-27 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021865D0 (en) * 2000-09-06 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021978D0 (en) * 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
WO2002051839A1 (en) * 2000-12-22 2002-07-04 Smithkline Beecham P.L.C. 5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione mesylate salt
ES2266593T3 (es) * 2001-11-21 2007-03-01 Smithkline Beecham Plc Edisilatos de rosiglitazona y su uso como antidiabeticos.
ES2278977T3 (es) * 2001-11-21 2007-08-16 Smithkline Beecham Plc Bencenosulfonato de 5-(4-(2-(n-metil-n-(2-piridil)amino)etoxi)bencil)tiazolidin-2,4-diona; procedimiento para su preparacion; polimorfos i, ii y iii de los mismos; y su uso como ingrediente activo farmaceutico.
AU2002350965A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0129851D0 (en) * 2001-12-13 2002-01-30 Smithkline Beecham Plc Novel compounds
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
WO2003050116A1 (en) * 2001-12-13 2003-06-19 Smithkline Beecham Plc A 5(-4-(2-(n-methyl-n-(2-pyridil)amino)ethoxy)benzyl)thiazolidine-2,4-dione (i) 10-camphorsulphonic acid salt and use against diabetes mellitus
AU2002352479A1 (en) * 2001-12-20 2003-07-09 Smithkline Beecham Plc 5- (4- (2- (n-methyl-n- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2, 4-dione malic acid salt and use against diabetes mellitus
GB0130510D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0130509D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0130511D0 (en) * 2001-12-20 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
WO2005023803A1 (en) * 2003-09-10 2005-03-17 Biocon Limited Phosphoric acid salt of 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl] methyl]- 2,4-thiazolidinedione

Also Published As

Publication number Publication date
CA2616031A1 (en) 2007-01-25
US20080207700A1 (en) 2008-08-28
EA012594B1 (ru) 2009-10-30
IL188661A0 (en) 2008-08-07
CN101228157A (zh) 2008-07-23
ZA200800184B (en) 2009-02-25
DE102005034406A1 (de) 2007-02-01
KR20080032108A (ko) 2008-04-14
EP1907386A1 (de) 2008-04-09
ATE469896T1 (de) 2010-06-15
BRPI0613686A2 (pt) 2011-01-25
UA92354C2 (en) 2010-10-25
EP1907386B1 (de) 2010-06-02
NO20080704L (no) 2008-02-07
JP2009502760A (ja) 2009-01-29
WO2007009799A1 (de) 2007-01-25
NZ565159A (en) 2010-01-29
ES2344662T3 (es) 2010-09-02
DE502006007113D1 (de) 2010-07-15
AU2006271863A1 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
EA200800065A1 (ru) Аминокислые соли росиглитазона
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
EA201100689A1 (ru) N-сульфонилпирролы и их применение в качестве ингибиторов гистондезацетилазы
EA201001359A1 (ru) Гетероциклические соединения в качестве ингибиторов cxcr2
ATE400567T1 (de) Kinaseinhibitoren
TW200745028A (en) Novel sulphonylpyrroles
UY29683A1 (es) Sales de 4-metil-n-(3-(4-metil-imidazol-1-il)-5-trifluorometil-fenil)-3-(4-piridin-3-il-pirimidin-2-ilamino)-benzamida
EA200601587A1 (ru) Новые амидозамещённые гидрокси-6-фенилфенантридины
TW200604184A (en) Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
TW200745027A (en) Novel sulphonylpyrroles
ATE471324T1 (de) Triazolophthalazine
RS52681B (en) HYDROBENZOATE SALTS OF METHANICOTINE COMPOUND
HN2005000477A (es) Compuestos de aminoheteroarilo sustituidos con piraol como inhibidores de proteina quinasa
EA200601568A1 (ru) Новые гидрокси-8-гетероарилфенантридины и их применение в качестве ингибиторов pde4
CY1110010T1 (el) Πυριδιναμινοσουλφονυλ υποκατεστημενα βενζαμιδια ως αναστολεις κυτοχρωματος ρ450 3α4 (cyp3a4)
DE112006002052A5 (de) Nicht-Peptidische Inhibitoren der AKAP-PKA-Wechselwirkung
NO20073368L (no) Amid-promedikament av gemcitabin, sammensetninger og anvendelse derav
EA200801199A1 (ru) Ингибиторы киназы
DOP2005000010A (es) Inhibidores de quinasa
EA201000566A1 (ru) Гетероциклические сетр ингибиторы
TW200619206A (en) Chemokine-binding heterocyclic compound salts, and methods of use thereof
EA201200891A1 (ru) Производные 3,4,4a,10d-тетрагидро-1h-тиопирано[4,3-c]изохинолина
EA200801145A1 (ru) Спироциклические производные хиназолина в качестве ингибиторов pde7
EA200802383A1 (ru) Полиморфные формы n-гидрокси-3-[4-[[[2-(2-метил-1h-индол-3-ил)этил]амино]метил]фенил]-2e-2-акриламида
EA200801365A1 (ru) Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU